Stage N2/IIIA Non Small Cell Lung Cancer: An Evidence-Based Review

Publisher： Bentham Science Publishers

E-ISSN： 1875-6301|3|2|127-139

ISSN： 1573-3947

Source： Current Cancer Therapy Reviews, Vol.3, Iss.2, 2007-05, pp. : 127-139

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Preoperative Concurrent Chemoradiotherapy for Stage IIIA Non-Small Cell Lung Cancer

By Ahn Yong Chan   Park Keunchil   Kim Dae Yong   Kim Kwan Min   Kim Jhingook   Shim Young Mog   Lee Kyung Soo   Han Joungho   Kim Ho Joong   Kwon O Jung   Lim Do Hoon   Noh Young Joo   Lee Jeong Eun   Huh Seung Jae  

Acta Oncologica, Vol. 40, Iss. 5, 2001-09 ,pp. : 588-592

Informa Healthcare

Access to resources Recommend Favorite

Carboplatin and paclitaxol (Taxol) as an induction regimen for patients with biopsy-proven stage IIIA N2 non-small cell lung cancer - an EORTC phase II study (EORTC 08958)

By O'Brien M.E.R.   Splinter T.   Smit E.F.   Biesma B.   Krzakowski M.   Tjan-Heijnen V.C.G.   Van Bochove A.   Stigt J.   Smid-Geirnaerdt M.J.A.   Debruyne C.   Legrand C.   Giaccone G.   for the EORTC Lung Cancer Group  

European Journal of Cancer, Vol. 39, Iss. 10, 2003-07 ,pp. : 1416-1422

Elsevier

Access to resources Recommend Favorite

Phase II trial of gemcitabine and docetaxel in patients with completely resected stage IIA–IIIA non-small-cell lung cancer

By Kawamura Masafumi   Eguchi Keisuke   Izumi Yotaro   Yamato Yasushi   Koike Teruaki   Sakaguchi Hirozo   Hada Enjo   Kobayashi Koichi  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 4, 2007-09 ,pp. : 495-501

Springer Publishing Company

Access to resources Recommend Favorite

Neoadjuvant chemoradiotherapy for stage III (N2/3) non-small-cell lung cancer: a review of prospective studies

By Robinson Cliff   Stephans Kevin  

Lung Cancer Management, Vol. 2, Iss. 1, 2013-02 ,pp. : 47-60

Future Medicine

Access to resources Recommend Favorite

Rapidly Alternating Combination of Cisplatin-based Chemotherapy and Hyperfractionated Accelerated Radiotherapy in Split Course for Stage IIIA and Stage IIIB Non-small Cell Lung Cancer: Results of a Phase I-II Study by the GOTHA Group

By Alberto P.   Mirimanoff R.O.   Mermillod B.   Leyvraz S.   Nagy-Mignotte H.   Bolla M.   Wellmann D.   Moro D.   Brambilla E.  

European Journal of Cancer, Vol. 31, Iss. 3, 1995-01 ,pp. : 342-348

Elsevier

Access to resources Recommend Favorite